Acta Dermato-Venereologica 99-9CompleteContent | Page 19
822
SHORT COMMUNICATION
Systemic Lupus Erythematosus with Familial Mediterranean Fever: Case Report and Review of Literature
Hiraku KOKUBU 1 , Hiroaki IDA 2 , Toshihiro TANAKA 1 and Noriki FUJIMOTO 1 *
Department of Dermatology, Shiga University of Medical Science, Setatsukinowa, Otsu, Shiga 520-2192, and 2 Division of Respirology,
Neurology, and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Fukuoka, Japan. *E-mail: noriki@
belle.shiga-med.ac.jp
1
Accepted Apr 16, 2019; E-published Apr 16, 2019
Systemic lupus erythematosus (SLE) is a systemic autoim
mune inflammatory disease characterized by antibody
production against cellular nuclear elements (1). On the
other hand, familial Mediterranean fever (FMF) is an auto-
inflammatory disorder, triggered by FMF-associated point
mutations. Recurrent high fever, generally above 38°C
for several days, is the most important symptom of FMF
accompanied by peritonitis, pleuritis, and arthritis without
deformity. Although colchicine is effective, corticoste
roids are not useful for symptom control (2). Fever, joint
pain, plaques, and pleurisy are common manifestations
of both of these diseases. Here, we present a rare case of
SLE with FMF and a literature review.
CASE REPORT
A 64-year-old Japanese man noticed joint pain in his shoulders,
elbows, and knees. He has frequently presented with fever over
38°C and indurated erythema for several days about once a month
since 2012. He has never experienced the same symptoms before,
and his family demonstrated no similar symptoms. His local der
matologist diagnosed him with Sweet’s syndrome from clinical and
histopathological features, and treated him with 5 to 20 mg a day of
oral corticosteroids. However, due to the recurrence of symptoms
he was referred to our hospital in 2013. Physical examination re
vealed persistent malar erythema and transient indurated erythema
on the upper extremities and trunk (Fig. 1A). He had non-erosive
arthritis on shoulders, elbows, and knees. He did not present with
swollen fingers, alopecia, lymphadenopathy, or oral ulcers. On the
first visit, the results of blood tests showed elevated levels of white
blood cell counts (9,000/µl), serum C-reactive protein (2.46 mg/
dl), IgG (1,910 mg/dl), and erythrocyte sedimentation rate (45.4
mm/h), but a decreased level of lymphocytes (927/µl). Serum le
vels of creatinine, creatine kinase and aldolase were within normal
limits. Urine examination showed no abnormalities. Anti-nuclear
antibody had a speckled pattern and the level was more than 2,560
times. Anti-U1 RNP antibody level was more than 300 U/ml. Au
toantibodies against double stranded DNA, smith, SS-A, SS-B, and
cyclic citrullinated peptide were not detected. A cutaneous biopsy
specimen from the erythema on his buttock showed perivascular
and lobular infiltration of lymphocytes and neutrophils in the dermis
and subcutaneous tissue (Fig. 1B). Vacuolar changes in the basal
layer and perifollicular inflammation were not observed (Fig. 1C).
Direct immunofluorescence showed no deposits of complement and
immunoglobulin. Computed tomography revealed mild interstitial
pneumonia, which we treated with low dose oral corticosteroids. We
initially diagnosed this case as SLE because of malar erythema, non-
erosive arthritis, lymphopenia and positive antinuclear antibody,
based on the criteria (1), and denied mixed connective tissue disease
due to the absence of swollen fingers and myositis. We added tacro
limus, since antimalarial drugs were not available in Japan. After
a short while, he complained of precordial pains, due to pleurisy.
We performed a mutational analysis of the familial Mediterranean
fever gene (MEFV), which showed heterozygous mutations in
exon 3; p.Arg408Gln and p.Pro369Ser. We suspected an atypical
FMF and additionally administered 0.5 mg dose of colchicine. His
precordial pains and fever improved even after the discontinuation
of tacrolimus, and we were able to reduce the dosage of cortico
steroids. We finally diagnosed the case as SLE with atypical FMF.
When the dosage of colchicine increased, he got moderate liver
damage. We continued with 0.5 mg dose of colchicine. We could
not increase the dosage of colchicine above 10 mg a day due to liver
dysfunction. Corticosteroids could not be decreased to less than 7
mg a day because of interstitial pneumonia. Thereafter, he has not
complained of repeated fever and precordial pains.
DISCUSSION
We considered this case as a combination of SLE and FMF
for several reasons. Firstly, there are no reports of SLE pa
tients having the MEFV gene mutations on exon 3 contrary
to exon 10 or exon 2 (3). Secondly, his symptoms improved
with colchicine. Third reason is that the positivity of anti-
U1 RNP antibody does not occur in FMF patients. Lastly,
interstitial pneumonia does not likely occur in FMF patients.
Differential diagnoses of the indurated erythema include
cutaneous lupus erythematosus, Sweet’s syndrome, and
neutrophil dermatosis. The typical skin lesion of FMF is a
well-defined erythematous plaque like erysipelas. Sweet’s
syndrome-like eruption has also been reported. Common
histological features include slight edema of the superfi
cial dermis and sparse perivascular infiltrate composed
of lymphocytes, neutrophils, and histiocytes (4). In our
Fig. 1. (A). Clinical presentation on
the first visit. Indurated erythemas
were observed on upper extremities
and trunk. (B). Histopathological
examination showed superficial and
perivascular infiltration of lympho
cytes throughout the dermis and
subcutaneous tissue (hema
toxylin-
eosin (H-E) staining, x40). (C)
Vacuolar changes in the basal layer
and perifollicular inflammation were
not observed (H-E x200).
doi: 10.2340/00015555-3197
Acta Derm Venereol 2019; 99: 822–823
This is an open access article under the CC BY-NC license. www.medicaljournals.se/acta
Journal Compilation © 2019 Acta Dermato-Venereologica.